Advertisement

Index by author

May 01, 1986; Volume 237,Issue 2

A

  1. Appel, J B

    1. Possible 5-hydroxytryptamine1 (5-HT1) receptor involvement in the stimulus properties of 1-(m-trifluoromethylphenyl)piperazine (TFMPP).
      K A Cunningham and J B Appel
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 369-377;

  2. Aravagiri, M

    1. Development and application of a specific radioimmunoassay for trifluoperazine N4'-oxide to a kinetic study in humans.
      M Aravagiri, E M Hawes and K K Midha
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 615-622;

  3. Atchison, W D

    1. Extracellular calcium-dependent and -independent effects of methylmercury on spontaneous and potassium-evoked release of acetylcholine at the neuromuscular junction.
      W D Atchison
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 672-680;

  4. Ator, N A

    1. Discriminative stimulus effects of atypical anxiolytics in baboons and rats.
      N A Ator and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 393-403;

B

  1. Babini, R

    1. Furosemide pharmacodynamics: effect of respiratory and acid-base disturbances.
      R Babini and P du Souich
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 623-628;

  2. Baez, A

    1. Prostaglandins participate in the renal vasodilation due to hydralazine in dogs.
      M Panzenbeck, A Baez and G Kaley
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 525-528;

  3. Bartholini, G

    1. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
      H Depoortere, B Zivkovic, K G Lloyd, D J Sanger, G Perrault, S Z Langer and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 649-658;

  4. Bayer, B M

    1. Inhibition of amino acid transport by nonsteroidal anti-inflammatory drugs: a model for predicting relative therapeutic potency.
      G F Seng and B M Bayer
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 496-503;

  5. Benckhuijsen, C

    1. Pharmacokinetics of melphalan in isolated perfusion of the limbs.
      C Benckhuijsen, F J Varossieau, A A Hart, J Wieberdink and J Noordhoek
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 583-588;

  6. Bennett, B M

    1. Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta.
      J F Brien, B E McLaughlin, T H Breedon, B M Bennett, K Nakatsu and G S Marks
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 608-614;
    2. Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate.
      B M Bennett, S M Kobus, J F Brien, K Nakatsu and G S Marks
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 629-635;

  7. Bernstein, P R

    1. Pharmacological evidence that human intralobar airways do not contain different receptors that mediate contractions to leukotriene C4 and leukotriene D4.
      C K Buckner, R D Krell, R B Laravuso, D B Coursin, P R Bernstein and J A Will
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 558-562;

  8. Bevan, J A

    1. Norepinephrine-sensitive, phenoxybenzamine-resistant receptor sites associated with contraction in rabbit arterial but not venous smooth muscle: possible role in adrenergic neurotransmission.
      I Laher, M A Khayal and J A Bevan
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 364-368;

  9. Bidiville, J

    1. Competition of organic anions for furosemide and p-aminohippurate secretion in the rabbit.
      J Bidiville and F Roch-Ramel
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 636-643;

  10. Bjorndahl, J M

    1. Effects of secretagogues on ATP levels and protein carboxyl methylation in rat brain synaptosomes.
      J M Bjorndahl and C O Rutledge
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 569-576;

  11. Bonanno, G

    1. Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum.
      M Raiteri, G Maura, G Bonanno and A Pittaluga
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 644-648;

  12. Breedon, T H

    1. Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta.
      J F Brien, B E McLaughlin, T H Breedon, B M Bennett, K Nakatsu and G S Marks
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 608-614;

  13. Breese, G R

    1. GABAergic modulation of inferior colliculus excitability: role in the ethanol withdrawal audiogenic seizures.
      G D Frye, T J McCown, G R Breese and S L Peterson
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 478-485;

  14. Brien, J F

    1. Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta.
      J F Brien, B E McLaughlin, T H Breedon, B M Bennett, K Nakatsu and G S Marks
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 608-614;
    2. Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate.
      B M Bennett, S M Kobus, J F Brien, K Nakatsu and G S Marks
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 629-635;

  15. Brown, J A

    1. Effects of thioglucoses on sensitivity to insulin hypoglycemic convulsions.
      M A Marrazzi, J A Brown, G Yabut, J Wright, M Poscher, P Rauch, D Silverstein, M Liveriatos and K W Fish
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 666-671;

  16. Buckner, C K

    1. Pharmacological evidence that human intralobar airways do not contain different receptors that mediate contractions to leukotriene C4 and leukotriene D4.
      C K Buckner, R D Krell, R B Laravuso, D B Coursin, P R Bernstein and J A Will
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 558-562;

C

  1. Chweh, A Y

    1. Effects of gamma-aminobutyric acid (GABA) receptor agonists on the neurotoxicity and anticonvulsant activity of barbiturates in mice.
      R A Ulloque, A Y Chweh and E A Swinyard
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 468-472;
    2. Effect of ethosuximide alone and in combination with gamma-aminobutyric acid receptor agonists on brain gamma-aminobutyric acid concentration, anticonvulsant activity and neurotoxicity in mice.
      E Lin-Michell, A Y Chweh and E A Swinyard
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 486-489;

  2. Claustre, Y

    1. Zolpidem, a novel nonbenzodiazepine hypnotic. II. Effects on cerebellar cyclic GMP levels and cerebral monoamines.
      B Scatton, Y Claustre, T Dennis and T Nishikawa
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 659-665;

  3. Cohen, R A

    1. Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade.
      R A Cohen
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 548-552;

  4. Condorelli, M

    1. Effects of prostaglandin synthesis inhibition on sympathetic-and parasympathetic-mediated coronary hemodynamic responses.
      B Trimarco, A Cuocolo, B Ricciardelli, P Patrignani, M Volpe, N de Luca and M Condorelli
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 589-599;

  5. Coursin, D B

    1. Pharmacological evidence that human intralobar airways do not contain different receptors that mediate contractions to leukotriene C4 and leukotriene D4.
      C K Buckner, R D Krell, R B Laravuso, D B Coursin, P R Bernstein and J A Will
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 558-562;

  6. Crampton, G H

    1. Xylazine emesis, yohimbine and motion sickness susceptibility in the cat.
      J B Lucot and G H Crampton
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 450-455;

  7. Cunningham, K A

    1. Possible 5-hydroxytryptamine1 (5-HT1) receptor involvement in the stimulus properties of 1-(m-trifluoromethylphenyl)piperazine (TFMPP).
      K A Cunningham and J B Appel
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 369-377;

  8. Cunny, H C

    1. Stereoselective behavioral effects of the isomers of pentobarbital and secobarbital in the pigeon.
      G R Wenger, J M Donald and H C Cunny
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 445-449;

  9. Cuocolo, A

    1. Effects of prostaglandin synthesis inhibition on sympathetic-and parasympathetic-mediated coronary hemodynamic responses.
      B Trimarco, A Cuocolo, B Ricciardelli, P Patrignani, M Volpe, N de Luca and M Condorelli
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 589-599;

D

  1. de Luca, N

    1. Effects of prostaglandin synthesis inhibition on sympathetic-and parasympathetic-mediated coronary hemodynamic responses.
      B Trimarco, A Cuocolo, B Ricciardelli, P Patrignani, M Volpe, N de Luca and M Condorelli
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 589-599;

  2. Dennis, T

    1. Zolpidem, a novel nonbenzodiazepine hypnotic. II. Effects on cerebellar cyclic GMP levels and cerebral monoamines.
      B Scatton, Y Claustre, T Dennis and T Nishikawa
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 659-665;

  3. Depoortere, H

    1. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
      H Depoortere, B Zivkovic, K G Lloyd, D J Sanger, G Perrault, S Z Langer and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 649-658;

  4. DeRossett, S E

    1. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
      S E DeRossett and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 437-444;

  5. Donald, J M

    1. Stereoselective behavioral effects of the isomers of pentobarbital and secobarbital in the pigeon.
      G R Wenger, J M Donald and H C Cunny
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 445-449;

  6. Durham, S

    1. Taurocholate and steroid glucuronides: mutual protection against cholestasis in the isolated perfused rat liver.
      S Durham and M Vore
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 490-495;

  7. du Souich, P

    1. Furosemide pharmacodynamics: effect of respiratory and acid-base disturbances.
      R Babini and P du Souich
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 623-628;

F

  1. Fish, K W

    1. Effects of thioglucoses on sensitivity to insulin hypoglycemic convulsions.
      M A Marrazzi, J A Brown, G Yabut, J Wright, M Poscher, P Rauch, D Silverstein, M Liveriatos and K W Fish
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 666-671;

  2. Fox, I H

    1. Inhibition of guinea-pig oxyntic cell function by adenosine and prostaglandins.
      A A Heldsinger, A I Vinik and I H Fox
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 351-356;

  3. Frye, G D

    1. GABAergic modulation of inferior colliculus excitability: role in the ethanol withdrawal audiogenic seizures.
      G D Frye, T J McCown, G R Breese and S L Peterson
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 478-485;

  4. Furchgott, R F

    1. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor.
      W Martin, R F Furchgott, G M Villani and D Jothianandan
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 529-538;
    2. Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor.
      W Martin, R F Furchgott, G M Villani and D Jothianandan
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 539-547;

G

  1. Gallaher, E J

    1. Benzodiazepine dependence in mice after ingestion of drug-containing food pellets.
      E J Gallaher, S A Henauer, C J Jacques and L E Hollister
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 462-467;

  2. Gemborys, M W

    1. Metabolism and excretion of a glutathione conjugate of acetaminophen in the isolated perfused rat kidney.
      J F Newton, D Hoefle, M W Gemborys, G H Mudge and J B Hook
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 519-524;

  3. Gil, D W

    1. Muscarinic cholinergic receptor binding sites differentiated by their affinity for pirenzepine do not interconvert.
      D W Gil and B B Wolfe
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 577-582;

  4. Goering, J

    1. Analysis of adrenoceptor blockade and hypotension elicited by urapidil and prazosin in conscious rat.
      J Goering and B G Zimmerman
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 553-557;

  5. Gordon, F J

    1. Central opioid receptors and baroreflex control of sympathetic and cardiovascular function.
      F J Gordon
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 428-436;

  6. Gormley, J M

    1. Inhibition of high-affinity choline uptake in the rat hippocampus by in vivo injection of phenobarbital in the medial septum.
      J A Richter and J M Gormley
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 563-568;

  7. Griffiths, R R

    1. Discriminative stimulus effects of atypical anxiolytics in baboons and rats.
      N A Ator and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 393-403;

H

  1. Hart, A A

    1. Pharmacokinetics of melphalan in isolated perfusion of the limbs.
      C Benckhuijsen, F J Varossieau, A A Hart, J Wieberdink and J Noordhoek
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 583-588;

  2. Hawes, E M

    1. Development and application of a specific radioimmunoassay for trifluoperazine N4'-oxide to a kinetic study in humans.
      M Aravagiri, E M Hawes and K K Midha
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 615-622;

  3. Heldsinger, A A

    1. Inhibition of guinea-pig oxyntic cell function by adenosine and prostaglandins.
      A A Heldsinger, A I Vinik and I H Fox
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 351-356;

  4. Henauer, S A

    1. Benzodiazepine dependence in mice after ingestion of drug-containing food pellets.
      E J Gallaher, S A Henauer, C J Jacques and L E Hollister
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 462-467;

  5. Hirsch, M D

    1. Structural modifications of pro-opiomelanocortin-derived peptides alter their behavioral effects markedly.
      M D Hirsch and T L O'Donohue
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 378-385;

  6. Hoefle, D

    1. Metabolism and excretion of a glutathione conjugate of acetaminophen in the isolated perfused rat kidney.
      J F Newton, D Hoefle, M W Gemborys, G H Mudge and J B Hook
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 519-524;

  7. Hollister, L E

    1. Benzodiazepine dependence in mice after ingestion of drug-containing food pellets.
      E J Gallaher, S A Henauer, C J Jacques and L E Hollister
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 462-467;

  8. Holtzman, S G

    1. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
      S E DeRossett and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 437-444;

  9. Hook, J B

    1. Metabolism and excretion of a glutathione conjugate of acetaminophen in the isolated perfused rat kidney.
      J F Newton, D Hoefle, M W Gemborys, G H Mudge and J B Hook
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 519-524;

I

  1. Ieni, J R

    1. Characterization and autoradiographic visualization of (+)-[3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/"sigma opiate" receptor commonality.
      R Sircar, R Nichtenhauser, J R Ieni and S R Zukin
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 681-688;

J

  1. Jacobson, A E

    1. Metaphit, a proposed phencyclidine receptor acylator: phencyclidine-like behavioral effects and evidence of absence of antagonist activity in pigeons and in rhesus monkeys.
      W Koek, J H Woods, A E Jacobson, K C Rice and R A Lessor
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 386-392;

  2. Jacques, C J

    1. Benzodiazepine dependence in mice after ingestion of drug-containing food pellets.
      E J Gallaher, S A Henauer, C J Jacques and L E Hollister
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 462-467;

  3. Jothianandan, D

    1. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor.
      W Martin, R F Furchgott, G M Villani and D Jothianandan
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 529-538;
    2. Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor.
      W Martin, R F Furchgott, G M Villani and D Jothianandan
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 539-547;

K

  1. Kaley, G

    1. Prostaglandins participate in the renal vasodilation due to hydralazine in dogs.
      M Panzenbeck, A Baez and G Kaley
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 525-528;

  2. Katz, L B

    1. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
      L B Katz, C K Scott and D A Shriver
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 404-410;

  3. Khayal, M A

    1. Norepinephrine-sensitive, phenoxybenzamine-resistant receptor sites associated with contraction in rabbit arterial but not venous smooth muscle: possible role in adrenergic neurotransmission.
      I Laher, M A Khayal and J A Bevan
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 364-368;

  4. Kobus, S M

    1. Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate.
      B M Bennett, S M Kobus, J F Brien, K Nakatsu and G S Marks
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 629-635;

  5. Koek, W

    1. Metaphit, a proposed phencyclidine receptor acylator: phencyclidine-like behavioral effects and evidence of absence of antagonist activity in pigeons and in rhesus monkeys.
      W Koek, J H Woods, A E Jacobson, K C Rice and R A Lessor
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 386-392;

  6. Krell, R D

    1. Pharmacological evidence that human intralobar airways do not contain different receptors that mediate contractions to leukotriene C4 and leukotriene D4.
      C K Buckner, R D Krell, R B Laravuso, D B Coursin, P R Bernstein and J A Will
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 558-562;

L

  1. Lagunoff, D

    1. Antagonism of the final common pathway of mast cell histamine secretion by arylalkylamines.
      G W Read and D Lagunoff
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 357-363;

  2. Laher, I

    1. Norepinephrine-sensitive, phenoxybenzamine-resistant receptor sites associated with contraction in rabbit arterial but not venous smooth muscle: possible role in adrenergic neurotransmission.
      I Laher, M A Khayal and J A Bevan
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 364-368;

  3. Langer, S Z

    1. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
      H Depoortere, B Zivkovic, K G Lloyd, D J Sanger, G Perrault, S Z Langer and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 649-658;

  4. Laravuso, R B

    1. Pharmacological evidence that human intralobar airways do not contain different receptors that mediate contractions to leukotriene C4 and leukotriene D4.
      C K Buckner, R D Krell, R B Laravuso, D B Coursin, P R Bernstein and J A Will
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 558-562;

  5. Lessor, R A

    1. Metaphit, a proposed phencyclidine receptor acylator: phencyclidine-like behavioral effects and evidence of absence of antagonist activity in pigeons and in rhesus monkeys.
      W Koek, J H Woods, A E Jacobson, K C Rice and R A Lessor
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 386-392;

  6. Lin-Michell, E

    1. Effect of ethosuximide alone and in combination with gamma-aminobutyric acid receptor agonists on brain gamma-aminobutyric acid concentration, anticonvulsant activity and neurotoxicity in mice.
      E Lin-Michell, A Y Chweh and E A Swinyard
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 486-489;

  7. Liveriatos, M

    1. Effects of thioglucoses on sensitivity to insulin hypoglycemic convulsions.
      M A Marrazzi, J A Brown, G Yabut, J Wright, M Poscher, P Rauch, D Silverstein, M Liveriatos and K W Fish
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 666-671;

  8. Lloyd, K G

    1. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
      H Depoortere, B Zivkovic, K G Lloyd, D J Sanger, G Perrault, S Z Langer and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 649-658;

  9. Lucot, J B

    1. Xylazine emesis, yohimbine and motion sickness susceptibility in the cat.
      J B Lucot and G H Crampton
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 450-455;

M

  1. Mandel, L J

    1. Cellular toxicity of bromobenzene and bromobenzene metabolites to rabbit proximal tubules: the role and mechanism of 2-bromohydroquinone.
      R G Schnellmann and L J Mandel
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 456-461;

  2. Manning, D C

    1. Two bradykinin binding sites with picomolar affinities.
      D C Manning, R Vavrek, J M Stewart and S H Snyder
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 504-512;

  3. Marks, G S

    1. Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta.
      J F Brien, B E McLaughlin, T H Breedon, B M Bennett, K Nakatsu and G S Marks
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 608-614;
    2. Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate.
      B M Bennett, S M Kobus, J F Brien, K Nakatsu and G S Marks
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 629-635;

  4. Marrazzi, M A

    1. Effects of thioglucoses on sensitivity to insulin hypoglycemic convulsions.
      M A Marrazzi, J A Brown, G Yabut, J Wright, M Poscher, P Rauch, D Silverstein, M Liveriatos and K W Fish
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 666-671;

  5. Martin, W

    1. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor.
      W Martin, R F Furchgott, G M Villani and D Jothianandan
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 529-538;
    2. Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor.
      W Martin, R F Furchgott, G M Villani and D Jothianandan
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 539-547;

  6. Maura, G

    1. Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum.
      M Raiteri, G Maura, G Bonanno and A Pittaluga
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 644-648;

  7. McCown, T J

    1. GABAergic modulation of inferior colliculus excitability: role in the ethanol withdrawal audiogenic seizures.
      G D Frye, T J McCown, G R Breese and S L Peterson
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 478-485;

  8. McLaughlin, B E

    1. Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta.
      J F Brien, B E McLaughlin, T H Breedon, B M Bennett, K Nakatsu and G S Marks
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 608-614;

  9. Midha, K K

    1. Development and application of a specific radioimmunoassay for trifluoperazine N4'-oxide to a kinetic study in humans.
      M Aravagiri, E M Hawes and K K Midha
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 615-622;

  10. Mudge, G H

    1. Metabolism and excretion of a glutathione conjugate of acetaminophen in the isolated perfused rat kidney.
      J F Newton, D Hoefle, M W Gemborys, G H Mudge and J B Hook
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 519-524;

N

  1. Nakatsu, K

    1. Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta.
      J F Brien, B E McLaughlin, T H Breedon, B M Bennett, K Nakatsu and G S Marks
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 608-614;
    2. Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate.
      B M Bennett, S M Kobus, J F Brien, K Nakatsu and G S Marks
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 629-635;

  2. Newton, J F

    1. Metabolism and excretion of a glutathione conjugate of acetaminophen in the isolated perfused rat kidney.
      J F Newton, D Hoefle, M W Gemborys, G H Mudge and J B Hook
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 519-524;

  3. Nichtenhauser, R

    1. Characterization and autoradiographic visualization of (+)-[3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/"sigma opiate" receptor commonality.
      R Sircar, R Nichtenhauser, J R Ieni and S R Zukin
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 681-688;

  4. Nishikawa, T

    1. Zolpidem, a novel nonbenzodiazepine hypnotic. II. Effects on cerebellar cyclic GMP levels and cerebral monoamines.
      B Scatton, Y Claustre, T Dennis and T Nishikawa
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 659-665;

  5. Noordhoek, J

    1. Pharmacokinetics of melphalan in isolated perfusion of the limbs.
      C Benckhuijsen, F J Varossieau, A A Hart, J Wieberdink and J Noordhoek
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 583-588;

O

  1. O'Donohue, T L

    1. Structural modifications of pro-opiomelanocortin-derived peptides alter their behavioral effects markedly.
      M D Hirsch and T L O'Donohue
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 378-385;

P

  1. Panzenbeck, M

    1. Prostaglandins participate in the renal vasodilation due to hydralazine in dogs.
      M Panzenbeck, A Baez and G Kaley
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 525-528;

  2. Patrignani, P

    1. Effects of prostaglandin synthesis inhibition on sympathetic-and parasympathetic-mediated coronary hemodynamic responses.
      B Trimarco, A Cuocolo, B Ricciardelli, P Patrignani, M Volpe, N de Luca and M Condorelli
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 589-599;

  3. Perrault, G

    1. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
      H Depoortere, B Zivkovic, K G Lloyd, D J Sanger, G Perrault, S Z Langer and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 649-658;

  4. Peterson, S L

    1. GABAergic modulation of inferior colliculus excitability: role in the ethanol withdrawal audiogenic seizures.
      G D Frye, T J McCown, G R Breese and S L Peterson
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 478-485;

  5. Pittaluga, A

    1. Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum.
      M Raiteri, G Maura, G Bonanno and A Pittaluga
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 644-648;

  6. Poscher, M

    1. Effects of thioglucoses on sensitivity to insulin hypoglycemic convulsions.
      M A Marrazzi, J A Brown, G Yabut, J Wright, M Poscher, P Rauch, D Silverstein, M Liveriatos and K W Fish
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 666-671;

R

  1. Raiteri, M

    1. Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum.
      M Raiteri, G Maura, G Bonanno and A Pittaluga
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 644-648;

  2. Rauch, P

    1. Effects of thioglucoses on sensitivity to insulin hypoglycemic convulsions.
      M A Marrazzi, J A Brown, G Yabut, J Wright, M Poscher, P Rauch, D Silverstein, M Liveriatos and K W Fish
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 666-671;

  3. Read, G W

    1. Antagonism of the final common pathway of mast cell histamine secretion by arylalkylamines.
      G W Read and D Lagunoff
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 357-363;

  4. Ricciardelli, B

    1. Effects of prostaglandin synthesis inhibition on sympathetic-and parasympathetic-mediated coronary hemodynamic responses.
      B Trimarco, A Cuocolo, B Ricciardelli, P Patrignani, M Volpe, N de Luca and M Condorelli
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 589-599;

  5. Rice, K C

    1. Metaphit, a proposed phencyclidine receptor acylator: phencyclidine-like behavioral effects and evidence of absence of antagonist activity in pigeons and in rhesus monkeys.
      W Koek, J H Woods, A E Jacobson, K C Rice and R A Lessor
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 386-392;

  6. Richter, J A

    1. Inhibition of high-affinity choline uptake in the rat hippocampus by in vivo injection of phenobarbital in the medial septum.
      J A Richter and J M Gormley
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 563-568;

  7. Roch-Ramel, F

    1. Competition of organic anions for furosemide and p-aminohippurate secretion in the rabbit.
      J Bidiville and F Roch-Ramel
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 636-643;

  8. Roeske, W R

    1. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
      M Watson, H I Yamamura and W R Roeske
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 411-418;
    2. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
      M Watson, W R Roeske and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 419-427;

  9. Rosenfeld, G C

    1. Prostaglandin E2 inhibition of secretagogue-stimulated [14C]aminopyrine accumulation in rat parietal cells: a model for its mechanism of action.
      G C Rosenfeld
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 513-518;

  10. Rutledge, C O

    1. Effects of secretagogues on ATP levels and protein carboxyl methylation in rat brain synaptosomes.
      J M Bjorndahl and C O Rutledge
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 569-576;

S

  1. Sanger, D J

    1. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
      H Depoortere, B Zivkovic, K G Lloyd, D J Sanger, G Perrault, S Z Langer and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 649-658;

  2. Scatton, B

    1. Zolpidem, a novel nonbenzodiazepine hypnotic. II. Effects on cerebellar cyclic GMP levels and cerebral monoamines.
      B Scatton, Y Claustre, T Dennis and T Nishikawa
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 659-665;

  3. Schnellmann, R G

    1. Cellular toxicity of bromobenzene and bromobenzene metabolites to rabbit proximal tubules: the role and mechanism of 2-bromohydroquinone.
      R G Schnellmann and L J Mandel
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 456-461;

  4. Scott, C K

    1. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
      L B Katz, C K Scott and D A Shriver
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 404-410;

  5. Seng, G F

    1. Inhibition of amino acid transport by nonsteroidal anti-inflammatory drugs: a model for predicting relative therapeutic potency.
      G F Seng and B M Bayer
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 496-503;

  6. Shriver, D A

    1. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
      L B Katz, C K Scott and D A Shriver
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 404-410;

  7. Silverstein, D

    1. Effects of thioglucoses on sensitivity to insulin hypoglycemic convulsions.
      M A Marrazzi, J A Brown, G Yabut, J Wright, M Poscher, P Rauch, D Silverstein, M Liveriatos and K W Fish
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 666-671;

  8. Sircar, R

    1. Characterization and autoradiographic visualization of (+)-[3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/"sigma opiate" receptor commonality.
      R Sircar, R Nichtenhauser, J R Ieni and S R Zukin
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 681-688;

  9. Snyder, S H

    1. Two bradykinin binding sites with picomolar affinities.
      D C Manning, R Vavrek, J M Stewart and S H Snyder
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 504-512;

  10. Souza, M R

    1. Halothane-cooling contractures of mammalian muscles.
      R T Sudo, M R Souza, G Zapata and G Suarez-Kurtz
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 600-607;

  11. Stewart, J M

    1. Two bradykinin binding sites with picomolar affinities.
      D C Manning, R Vavrek, J M Stewart and S H Snyder
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 504-512;

  12. Suarez-Kurtz, G

    1. Halothane-cooling contractures of mammalian muscles.
      R T Sudo, M R Souza, G Zapata and G Suarez-Kurtz
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 600-607;

  13. Sudo, R T

    1. Halothane-cooling contractures of mammalian muscles.
      R T Sudo, M R Souza, G Zapata and G Suarez-Kurtz
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 600-607;

  14. Swinyard, E A

    1. Effects of gamma-aminobutyric acid (GABA) receptor agonists on the neurotoxicity and anticonvulsant activity of barbiturates in mice.
      R A Ulloque, A Y Chweh and E A Swinyard
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 468-472;
    2. Effect of ethosuximide alone and in combination with gamma-aminobutyric acid receptor agonists on brain gamma-aminobutyric acid concentration, anticonvulsant activity and neurotoxicity in mice.
      E Lin-Michell, A Y Chweh and E A Swinyard
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 486-489;

T

  1. Trachte, G J

    1. Thromboxane agonist (U46619) potentiates norepinephrine efflux from adrenergic nerves.
      G J Trachte
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 473-477;

  2. Trimarco, B

    1. Effects of prostaglandin synthesis inhibition on sympathetic-and parasympathetic-mediated coronary hemodynamic responses.
      B Trimarco, A Cuocolo, B Ricciardelli, P Patrignani, M Volpe, N de Luca and M Condorelli
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 589-599;

U

  1. Ulloque, R A

    1. Effects of gamma-aminobutyric acid (GABA) receptor agonists on the neurotoxicity and anticonvulsant activity of barbiturates in mice.
      R A Ulloque, A Y Chweh and E A Swinyard
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 468-472;

V

  1. Varossieau, F J

    1. Pharmacokinetics of melphalan in isolated perfusion of the limbs.
      C Benckhuijsen, F J Varossieau, A A Hart, J Wieberdink and J Noordhoek
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 583-588;

  2. Vavrek, R

    1. Two bradykinin binding sites with picomolar affinities.
      D C Manning, R Vavrek, J M Stewart and S H Snyder
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 504-512;

  3. Villani, G M

    1. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor.
      W Martin, R F Furchgott, G M Villani and D Jothianandan
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 529-538;
    2. Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor.
      W Martin, R F Furchgott, G M Villani and D Jothianandan
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 539-547;

  4. Vinik, A I

    1. Inhibition of guinea-pig oxyntic cell function by adenosine and prostaglandins.
      A A Heldsinger, A I Vinik and I H Fox
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 351-356;

  5. Volpe, M

    1. Effects of prostaglandin synthesis inhibition on sympathetic-and parasympathetic-mediated coronary hemodynamic responses.
      B Trimarco, A Cuocolo, B Ricciardelli, P Patrignani, M Volpe, N de Luca and M Condorelli
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 589-599;

  6. Vore, M

    1. Taurocholate and steroid glucuronides: mutual protection against cholestasis in the isolated perfused rat liver.
      S Durham and M Vore
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 490-495;

W

  1. Watson, M

    1. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
      M Watson, H I Yamamura and W R Roeske
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 411-418;
    2. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
      M Watson, W R Roeske and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 419-427;

  2. Wenger, G R

    1. Stereoselective behavioral effects of the isomers of pentobarbital and secobarbital in the pigeon.
      G R Wenger, J M Donald and H C Cunny
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 445-449;

  3. Wieberdink, J

    1. Pharmacokinetics of melphalan in isolated perfusion of the limbs.
      C Benckhuijsen, F J Varossieau, A A Hart, J Wieberdink and J Noordhoek
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 583-588;

  4. Will, J A

    1. Pharmacological evidence that human intralobar airways do not contain different receptors that mediate contractions to leukotriene C4 and leukotriene D4.
      C K Buckner, R D Krell, R B Laravuso, D B Coursin, P R Bernstein and J A Will
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 558-562;

  5. Wolfe, B B

    1. Muscarinic cholinergic receptor binding sites differentiated by their affinity for pirenzepine do not interconvert.
      D W Gil and B B Wolfe
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 577-582;

  6. Woods, J H

    1. Metaphit, a proposed phencyclidine receptor acylator: phencyclidine-like behavioral effects and evidence of absence of antagonist activity in pigeons and in rhesus monkeys.
      W Koek, J H Woods, A E Jacobson, K C Rice and R A Lessor
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 386-392;

  7. Wright, J

    1. Effects of thioglucoses on sensitivity to insulin hypoglycemic convulsions.
      M A Marrazzi, J A Brown, G Yabut, J Wright, M Poscher, P Rauch, D Silverstein, M Liveriatos and K W Fish
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 666-671;

Y

  1. Yabut, G

    1. Effects of thioglucoses on sensitivity to insulin hypoglycemic convulsions.
      M A Marrazzi, J A Brown, G Yabut, J Wright, M Poscher, P Rauch, D Silverstein, M Liveriatos and K W Fish
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 666-671;

  2. Yamamura, H I

    1. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
      M Watson, H I Yamamura and W R Roeske
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 411-418;
    2. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
      M Watson, W R Roeske and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 419-427;

Z

  1. Zapata, G

    1. Halothane-cooling contractures of mammalian muscles.
      R T Sudo, M R Souza, G Zapata and G Suarez-Kurtz
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 600-607;

  2. Zimmerman, B G

    1. Analysis of adrenoceptor blockade and hypotension elicited by urapidil and prazosin in conscious rat.
      J Goering and B G Zimmerman
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 553-557;

  3. Zivkovic, B

    1. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
      H Depoortere, B Zivkovic, K G Lloyd, D J Sanger, G Perrault, S Z Langer and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 649-658;

  4. Zukin, S R

    1. Characterization and autoradiographic visualization of (+)-[3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/"sigma opiate" receptor commonality.
      R Sircar, R Nichtenhauser, J R Ieni and S R Zukin
      Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 681-688;
Back to top

In this issue

Advertisement